Phase I study of the PI3K/mTOR inhibitor PF-05212384 in combination with other antitumor agents / Z.A. Wainberg, G.S.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 33:15 suppl.(2015 May), pp. 2590.1-2590.1. (51. Annual Meeting of the American Society of Clinical Oncology (ASCO): Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer : May 29-June 02 Chicago (Illinois) 2015) [10.1200/JCO.2015.33.15_SUPPL.2590].
Phase I study of the PI3K/mTOR inhibitor PF-05212384 in combination with other antitumor agents
G. Curigliano;
2015
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
